Salunkhe Sonali S, Alzahrani Sahal, Ugiliweneza Beatrice
Idaho State University.
Saudi Electronic University.
J Appalach Health. 2023 Dec 1;5(3):38-52. doi: 10.13023/jah.0503.04. eCollection 2023.
In the opioid epidemic, the U.S. faces a significant public health crisis, with some areas of the country, such as rural and Appalachian regions, suffering more than others. The differential regional impact of the crisis in Kentucky-a state with both non-metropolitan/metropolitan and Appalachian/Non-Appalachian statuses-has not yet been documented despite such knowledge being essential to the success of overdose prevention efforts.
This study compares all-cause, drug- and opioid-related mortality between counties in different regions of Kentucky: Appalachian non-metropolitan, Appalachian metropolitan, non-Appalachian non-metropolitan, and non-Appalachian metropolitan.
Age-adjusted mortality data from the Centers for Disease Control and Prevention's Wide-ranging Online Data for Epidemiologic Research (CDC WONDER, 2000-2019) were used. County-level demographic and socioeconomic data were obtained from the U.S. Census Bureau, 2010 American Community Survey. Statistical analyses were performed with negative binomial regression models with a log link.
The Appalachian non-metropolitan region of Kentucky had a significantly higher (p < .05) all-cause mortality (1,076/100,000) compared to the state's non-Appalachian metropolitan (904/100,000), non-Appalachian non-metropolitan (959/100,000), and Appalachian metropolitan (938/100,000) regions. Within non-Appalachian regions, non-metropolitan rates were higher than metropolitan (p = .0006). For drug- and opioid-related mortality, non-metropolitan and metropolitan regions had comparable rates within non-Appalachia, as well as within Appalachia. Appalachian regions had twice the mortality rates of non-Appalachian regions of the state (p < .05). Among the Appalachian counties, non-metropolitan counties had higher all-cause mortality than metropolitan counties.
The findings from this study can help healthcare practitioners and public health officials develop interventions addressing drug-related and opioid-related mortality in Kentucky targeted to the regions where rates are significantly higher. Also, the information on geographic, demographic, and socioeconomic factors related to these types of mortality can be used to design interventions specific to the target population's socio-demographics.
在美国阿片类药物泛滥的情况下,该国面临着重大的公共卫生危机,美国的一些地区,如农村和阿巴拉契亚地区,受灾情况比其他地区更为严重。尽管了解危机在肯塔基州不同地区的差异影响对于预防药物过量工作的成功至关重要,但该州具有非大都市/大都市以及阿巴拉契亚/非阿巴拉契亚双重身份,这种差异影响尚未得到记录。
本研究比较了肯塔基州不同地区各县的全因死亡率、与毒品及阿片类药物相关的死亡率,这些地区包括:阿巴拉契亚非大都市地区、阿巴拉契亚大都市地区、非阿巴拉契亚非大都市地区和非阿巴拉契亚大都市地区。
使用了美国疾病控制与预防中心的广泛流行病学研究在线数据(CDC WONDER,2000 - 2019年)中的年龄调整死亡率数据。县级人口和社会经济数据来自美国人口普查局2010年美国社区调查。采用带有对数链接的负二项回归模型进行统计分析。
肯塔基州的阿巴拉契亚非大都市地区的全因死亡率(1076/10万)显著高于该州的非阿巴拉契亚大都市地区(904/10万)、非阿巴拉契亚非大都市地区(959/10万)和阿巴拉契亚大都市地区(938/10万)(p < 0.05)。在非阿巴拉契亚地区内,非大都市地区的死亡率高于大都市地区(p = 0.0006)。对于与毒品及阿片类药物相关的死亡率,非阿巴拉契亚地区内以及阿巴拉契亚地区内的非大都市和大都市地区的死亡率相当。阿巴拉契亚地区的死亡率是该州非阿巴拉契亚地区的两倍(p < 0.05)。在阿巴拉契亚各县中,非大都市县的全因死亡率高于大都市县。
本研究结果可帮助医疗从业者和公共卫生官员制定针对肯塔基州与毒品及阿片类药物相关死亡率的干预措施,目标是死亡率显著较高的地区。此外,与这些类型死亡率相关的地理、人口和社会经济因素信息可用于设计针对目标人群社会人口特征的干预措施。